Medical Equipment Industry Overview

The buccal drug delivery system refers to the injection of the desired medicine through the buccal mucosal membrane lining of the mouth cavity. This method is effective for administering mucosal and transmucosal drugs. Mucosal drug delivery aims for site-specific drug release on the mucosa, whereas transmucosal permeation entails drug absorption across the mucosal barrier and into the systemic circulation. The main types of buccal drug delivery systems are sublingual, buccal tablets and lozenges, and oral sprays. The term "sublingual" refers to the route of administration for systemic medication delivery of the buccal drugs. These are used in various applications such as pain management, smoking cessation, and angina pectoris and are used by hospitals, ambulatory care centers, and others. The buccal drug delivery system market research report is one of a series of new reports from The Business Research Company that provides buccal drug delivery system market statistics, including buccal drug delivery system industry global market size, regional shares, competitors with a buccal drug delivery system market share, detailed buccal drug delivery system market segments, market trends and opportunities, and any further data you may need to thrive in the buccal drug delivery system industry. This buccal drug delivery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global buccal drug delivery systems market size is expected to grow from $2.97 billion in 2022 to $2.97 billion in 2023 at a compound annual growth rate (CAGR) of 10.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The buccal drug delivery systems market is expected to grow to $4.76 billion in 2027 at a CAGR of 9.7%. The rising prevalence of chronic diseases is expected to propel the growth of the buccal drug delivery systems market going forward. Chronic diseases refer to ailments that persist for a year or longer, such as cancer, heart disease, stroke, diabetes, cancer, and arthritis. These are the most prevalent chronic illnesses that can be managed but not cured and necessitate continuous nutrition and medical care. Buccal drug delivery systems provide appropriate and effective drug delivery for administering mucosal and transmucosal drugs that are required by several patients suffering from chronic diseases such as diabetes and cancer. For instance, in September 2020, according to a study report issued by the American Action Forum, chronic illness frequency and expenses are increasing in the United States. Chronic illness is anticipated to continue increasing as the incidence of illness among children and young people increases. Chronic illness is a significant healthcare issue since it costs the US $3.7 trillion annually, or about 19.6% of the GDP, and is rising. Therefore, the rising prevalence of chronic diseases drives the buccal drug delivery systems market. Investments in injectable drug delivery systems are a key trend gaining popularity in the buccal drug delivery systems market. Major pharmaceutical companies are investing in drug delivery systems to sustain their position in the market. For instance, in September 2021, Novartis, a Switzerland-based pharmaceutical company, invested approximately $40 million in Credence MedSystems, a US-based company that develops innovative drug delivery systems. The aim of the investment is to boost the production of injectable drug delivery systems. In November 2020, Novo Nordisk, a Denmark-based pharmaceutical company, acquired Emisphere Technologies for a total amount of $ 1.8 billion. With this acquisition, Novo Nordisk eliminates any future royalty liabilities to Emisphere and MHR and gains full access to the Eligen SNAC technology platform, which enables it to diversify its oral drug portfolio assets across therapeutic areas. Emisphere Technologies is a US-based drug delivery company that develops improved oral formulations and active pharmaceutical ingredients. Major players in the buccal drug delivery system market are Teva Pharmaceuticals Limited, Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior Pharmaceuticals, Generex Biotechnology, Catalent, Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, MedLab, AstraZeneca, F. Hoffmann-La Roche Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, and Novo Nordisk A/S. North America was the largest region in the buccal drug delivery systems market in 2022. The regions covered in the buccal drug delivery system report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the buccal drug delivery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The buccal drug delivery system market consists of the sales of drug ingredients such as insulin, nicotine, tizanidine, triptan, nifedipine, flurbiprofen, sodium carboxymethylcellulose, carbopol, glibenclamide, hyaluronic acid, and xanthan gum. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.   The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global buccal drug delivery system market is segmented - 1) By Type: Sublingual, Buccal Tablets and Lozenges, Oral Sprays 2) By Application: Pain Management, Smoking Cessation, Angina Pectoris 3) By End-User: Hospitals, Ambulatory Centers, Other End-Users

Colored contact lenses are specially designed lenses that allow a person to change the colour of their eyes for a special event. The primary goal is to enhance the wearer's natural eye colour. The main types of products covered by colored contact lenses are soft contact lenses, RGP lenses, and hybrid lenses. Soft contact lenses refer to plastic lenses that are flexible and soft, allowing oxygen to reach the cornea. The materials used in the preparation of colored contact lenses are polymer and hydrogen for various applications, such as with and without vision correction. It is distributed through retail stores, online stores, and others.   The colored contact lenses market research report is one of a series of new reports from The Business Research Company that provides colored contact lenses market statistics, including the colored contact lenses industry's global market size, regional shares, competitors with a colored contact lenses market share, detailed colored contact lenses market segments, market trends and opportunities, and any further data you may need to thrive in the colored contact lenses industry. This colored contact lenses market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global coloured contact lenses market size is expected to grow from $3.27 billion in 2022 to $3.62 billion in 2023 at a compound annual growth rate (CAGR) of 10.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The coloured contact lenses market is expected to grow to $5.19 billion in 2027 at a CAGR of 9.4%. An increasing number of eye disorders is expected to propel the growth of the colored contact lens market going forward. An eye disorder refers to various eye problems resulting in blindness and low vision that may be caused by infection, allergy, or vitamin deficiency. Colored contact lenses improve or change the appearance of the eye and can be used to address common visual disorders such as astigmatism, nearsightedness, or farsightedness. For instance, in February 2021, according to the Global Eye Health report published by The Lancet Global Health, a US-based, internationally trusted source of global public health knowledge, a projected 596 million people globally, including 43 million blind people, have distance vision impairment. Another 510 million people had uncorrected nearsightedness due to a lack of reading glasses. As a result of population aging, growth, and urbanization, a projected 895 million individuals will have distance vision impairment by 2050, of whom 61 million will be blind. Therefore, an increasing number of eye disorders are driving the growth of the colored contact lens market. Technological advancements are a key trend gaining popularity in the colored contact lens market. Major companies operating in the colored contact lens market are focused on innovating new technologies to sustain their position in the market. For instance, in July 2020, Perfect Corp., a US-based beauty tech solutions provider, partnered with a US-based multinational corporation, Johnson & Johnson, to launch contact lens AR virtual try-on within its ACUVUE flagship Taobao and WeChat mini-programs. This is the first colored contact lens virtual try-on service using AR technology that is available on Taobao and WeChat micro-programs. The precise eye position may be detected using Perfect Corp.'s cutting-edge facial recognition technology, which also enables a realistic AR virtual contact lens try-on. Colored contact lenses and AR+AI beauty technology are going beyond virtual makeup try-ons. This innovative online solution is expected to provide customers with a comprehensive, immersive, and hyper-realistic augmented reality beauty experience. In September 2022, Black Pearl Global Investments, a US-based asset management firm focused on investing in healthcare, acquired Hydrogel Vision Corp. (HVC) for an undisclosed amount. With this acquisition, HVC will now be known as Black Pearl Vision, making it the only company in the world that is both owned and operated by people of color and women. Hydrogel Vision Corp. (HVC) is a US-based manufacturer and distributor of high-performance contact lenses for men and women. Major players in the coloured contact lenses market are CooperVision Inc., Alcon, Bausch + Lomb, Menicon Co. Ltd., Johnson & Johnson, Carl Zeiss AG, Novartis AG, Hoya Corporation, QualiMed Srl, Essilor International, UltraVision CLPL, Clearlab SG Pte Ltd., Oculus Private Limited, Camax Optical Corp., and SEED Co. Ltd. North America was the largest region in the coloured contact lenses market in 2022. The regions covered in the coloured contact lenses report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the coloured contact lenses market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The colored contact lens market consists of sales of visibility tint, enhancement tint, and opaque tint. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.   The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global coloured contact lenses market is segmented - 1) By Product Type: Soft Contact Lenses, RGP Lenses, and Hybrid Lenses 2) By Material: Polymer, Hydrogen 3) By Application: With Vision Correction, Without Vision Correction 4) By End-Users: Retail Stores, Online Stores, Other Stores

A faecal extraction system is a device or instrument that collects faeces samples to identify pathogens, microbes, or parasite particles that could be present inside the stool.  The main types of assays in faecal extraction systems are calprotectin, albumin, hemoglobin, and bile acids. Calprotectin is a biochemical measurement of protein in stools, used to detect inflammation in the intestines. The analysis tests include microscopic, chemical, immunological, and microbiological ones for indications such as parasitic infection, viral infection, bacterial indication, and poor nutrient absorption. These are used by various end users, such as diagnostic centers, hospitals, clinics, ambulatory clinics, and research centers.   The faecal extraction systems market research report is one of a series of new reports from The Business Research Company that provides faecal extraction systems market statistics, including faecal extraction systems industry global market size, regional shares, competitors with a faecal extraction systems market share, detailed faecal extraction systems market segments, market trends and opportunities, and any further data you may need to thrive in the faecal extraction systems industry. This faecal extraction systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global faecal extraction systems market size is expected to grow from $1.60 billion in 2022 to $1.67 billion in 2023 at a compound annual growth rate (CAGR) of 4.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The  faecal extraction systems market is expected to grow to $1.94 billion in 2027 at a CAGR of 3.8%. The increasing prevalence of inflammatory bowel disease is expected to propel the growth of the faecal extraction systems market going forward. Inflammatory bowel disease (IBD) is a category of illnesses characterised by long-term (chronic) inflammation of digestive system tissues. Faecal extraction systems are used for the diagnosis, monitoring of disease activity, treatment guidance, and prediction of disease relapse and post-operative recurrence in inflammatory bowel disease. As a result, the increasing prevalence of inflammatory bowel disease increases the demand for faecal extraction systems. For instance, in 2022, according to reports in Oxford Academic, a UK-based journal, a total of 42,498 IBD cases were identified in 2020 (during the last two decades), out of which 31,372 were affected by ulcerative colitis and 11,126 were affected by Crohn's disease. Therefore, the increasing prevalence of inflammatory bowel disease in faecal extraction systems is expected to drive the growth of the faecal extraction systems market. Advancement in medical technologies in faecal extraction systems is a key trend gaining popularity in the faecal extraction systems market. The advancements in medical technologies of faecal extraction include specimens preserved in formalin, flotation techniques, sedimentation techniques, and gut microbiomes. For instance, in August 2020, MP Biomedicals, a US-based diagnostic products manufacturer launched the MagBeads FastDNA kit for feces based on magnetic beads technology. It allows for high yield and quick isolation of genomic DNA from faecal samples. The unique features of the kit include prewash buffers to effectively remove contaminants and inhibitors before the lysis process and lysis buffers to protect released DNA and remove unwanted RNA. Growing expenditure in the healthcare sector is expected to propel the growth of the faecal extraction systems market going forward. Healthcare expenditure is the total cost of health care (including both public and private spending) expressed as a percentage of GDP. Rising healthcare expenditure helps faecal extraction system device manufacturers develop productivity, which increases demand for the faecal extraction systems market. For instance, according to the Organisation for Economic Co-operation and Development, a France-based intergovernmental economic organization, in 2020 health spending as a share of GDP jumped to 9.7% across OECD countries, up from 8.8% in the previous year. A group of 17 OECD countries suggests that health spending continued to grow strongly in 2021 by around 6%. Therefore, growing expenditure for the healthcare sector is driving the growth of the faecal extraction systems market. Major players in the faecal extraction systems market are ALPCO, Alpha Laboratories, Arbor Assays, BioMérieux, BÜHLMANN, Calpro AS, Cancax Biotech, DRG INSTRUMENTS GMBH, Promega Corporation, Werfen, Mobidiag, Autogen, Microbiome, Biohit Healthcare Ltd., and Meridian Bioscience. North America was the largest region in the faecal extraction systems market in 2022. The regions covered in the faecal extraction system report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the faecal extraction system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The faecal extraction system market consists of sales of stool pre-processing devices, and stool extraction devices,. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global faecal extraction systems market is segmented - 1) By Assay: Calprotectin, Albumin, Haemoglobin, Bile Acids 2) By Analysis Test: Microscopic, Chemical, Immunological, Microbiological 3) By Indication: Parasitic Infection, Viral Infection, Bacterial Indication, Poor Nutrient Absorption 4) By End-Use: Diagnostic Centers, Hospitals & Clinics, Ambulatory Clinics, Research Centers

The term "non-invasive brain trauma monitoring devices" refers to devices that aid in monitoring neural and electrical activity and the pressure surrounding the brain. These devices help analyze the blood flow rate in the brain's arteries and veins in cases of brain death, trauma-related brain injury, epilepsy, and other conditions of this nature. The main types of non-invasive brain trauma monitoring devices are the non-invasive intracranial pressure monitor, the non-invasive cerebral edoema dynamic monitor, and others. The non-invasive intracranial pressure monitor refers to a pressure monitor used in the management of various neurological conditions. The non-invasive intracranial pressure monitor is an invasive system with several complications that consists of a ventricular catheter connected to an external strain gauge. The applications of non-invasive brain trauma monitoring devices include cardiology, urology, and nephrology, oncology, gastroenterology, and other applications that are used in hospitals, neurological centers, and by other end users. The non-invasive brain trauma monitoring devices market research report is one of a series of new reports from The Business Research Company that provides non-invasive brain trauma monitoring devices market statistics, including non-invasive brain trauma monitoring devices industry global market size, regional shares, competitors with a non-invasive brain trauma monitoring devices market share, detailed non-invasive brain trauma monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive brain trauma monitoring devices industry. This non-invasive brain trauma monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global non-invasive brain trauma monitoring devices market size is expected to grow from $7.19 billion in 2022 to $7.93 billion in 2023 at a compound annual growth rate (CAGR) of 10.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The non-invasive brain trauma monitoring devices market is expected to grow to $11.55 billion in 2027 at a CAGR of 9.8%. The increased prevalence of neurological disorders and diseases is expected to propel the demand for non-invasive brain trauma monitoring devices. Neurological disorders are one of the major non-communicable diseases (NCDs) that impact people's thoughts, emotions, behavior, and injuries like brain injury, spinal cord injury, or nerve injury. Non-invasive brain trauma monitoring devices help in continuous monitoring and allow physicians to determine the critical level of patients and what actions should be taken to reduce the critical trauma condition of patients. For instance, the World Health Organization (WHO), a Swiss-based health body of the United Nations, estimates that 50 million people worldwide suffered from epilepsy in 2022, with approximately 80% of those individuals residing in low- and middle-income nations. Therefore, the rise in neurological disorders and diseases will drive the market for non-invasive brain trauma monitoring devices. Technological advancement is a key trend gaining popularity in the non-invasive brain trauma monitoring devices market. Major companies operating in non-invasive brain trauma monitoring devices are developing advanced technologies to strengthen their market position. For instance, in June 2021, FieldLine Inc., a US-based brain imaging manufacturer of quantum sensors, launched the HEDscan system, a wearable, non-invasive magnetoencephalography (MEG) device based on optically pumped magnetometer (OPM) sensor technology. This device generates 3D videos of brain activity by using 128 synchronized quantum magnetic sensors built with FieldLine's microfabrication techniques. In November 2022, SonderMind, a US-based digital behavioral health company, acquired Total Brain for an undisclosed amount. Through this acquisition, SonderMind will help their therapists track treatment results, offer enterprise clients population health reporting, and give insurers and healthcare organizations a complete offering. Total Brain is a US-based company operating in brain monitoring. Major players in the non-invasive brain trauma monitoring devices market are Covidien PLC, Hitachi Medical Corporation, Koninklijke Philips N.V., NeuroLogica Corp., NeuroWave Systems Inc., Noraxon U.S.A., RAUMEDIC AG, and Sense Neuro Diagnostics. North America was the largest region in the non-invasive brain trauma monitoring devices market in 2022. The regions covered in the non-invasive brain trauma monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the non-invasive brain trauma monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The non-invasive brain trauma monitoring devices market consists of sales of monitoring devices, consumables, and accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global non-invasive brain trauma monitoring devices market is segmented - 1) By Type: Non-invasive Intracranial Pressure Monitor, Non-invasive Cerebral Edema Dynamic Monitor, Other Types 2) By Application: Cardiology, Urology, and Nephrology; Oncology; Gastroenterology; Other Applications 3) By End-User: Hospitals, Neurological Centers, and Other End Users

Optical imaging refers to a method for non-invasive investigation of cellular and molecular structures in the living body. The exceptional characteristics of photons help the imaging process generate comprehensive and precise images of smaller structures, from cells and molecules to bigger structures like tissues and organs. The main products of optical imaging include imaging systems, cameras, software, and others. The imaging systems use light and the special properties of photons to obtain detailed images of organs, tissues, cells, and even molecules. The techniques offer minimally or non-invasive methods for looking inside the patient's body. Applications of optical imaging include pathological imaging and intra-operative imaging. The various end-users of optical imaging are hospitals and clinics, research laboratories, and the pharmaceutical and biotechnology industries. The optical imaging market research report is one of a series of new reports from The Business Research Company that provides optical imaging market statistics, including optical imaging industry global market size, regional shares, competitors with an optical imaging market share, detailed optical imaging market segments, market trends and opportunities, and any further data you may need to thrive in the optical imaging industry. This optical imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global optical imaging market size is expected to grow from $1.87 billion in 2022 to $2.12 billion in 2023 at a compound annual growth rate (CAGR) of 13.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The optical imaging market is expected to grow to $3.53 billion in 2027 at a CAGR of 13.6%. Rising ageing population is expected to propel the growth of the optical imaging market. The geriatric population refers to a population of people aged 65 and older. The optical imaging technology offers great flexibility owing to its high resolution and multispectral potential, which helps in the diagnosis and treatment of atherosclerosis and related diseases in the geriatric population. Optical imaging techniques use non-ionizing radiation, keeping the adverse effects of radiation in check, causing increased adoption in hospitals for treating older people. For example, according to the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, in October 2021, between 2015 and 2050, the proportion of the world's population over 60 years old will approximately double from 12% to 22%. By 2050, 80% of older people will be living in low- and middle-income countries. Therefore, a rising ageing population is expected to propel the growth of the optical imaging market. The new advancements in technologies are a key trend gaining popularity in the optical imaging market. Major players are launching technologically advanced products to stay ahead in the optical imaging market and gain a prominent market share. For instance, in May 2020, GOKO Imaging Devices Co., Ltd. introduced a new product called "Camera Handgrip." This can be attached to the ultra-high magnification capillary scope GOKO Bscan-Z, which non-invasively observes the shape and flow of skin capillaries in the whole body. Furthermore, in November 2020, Leica Microsystems launched its next-generation EnFocus intraoperative Optical Coherence Tomography (OCT) solution that is built into the Proveo 8 ophthalmic microscope. The innovative ophthalmology portfolio has been developed to support surgical workflow and help ophthalmic surgeons focus on perfection during posterior and anterior segment surgery. In December 2020, ZEISS, a Germany-based firm operating in the fields of optics and optoelectronics, acquired a majority stake in the imaging business of Arivis AG for an undisclosed amount. The acquisition supports research pursuits in ZEISS’ microscopy business. Arivis AG is a Germany-based developer and designer of software for the visualization and analysis of 2D, 3D, and 4D image data. Major players in the optical imaging market are St. Jude Medical Inc., PerkinElmer Inc., Carl Zeiss Meditec AG, Koninklijke Philips, Topcon Corporation, Bioptigen Inc., Canon Inc., Heidelberg Engineering Inc., Optovue Inc., Headwall Photonics Inc., and Agfa-Gevaert N.V. North America was the largest region in the optical imaging market in 2022. The regions covered in the optical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the optical imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The optical imaging market consists of sales of optical coherence tomography, diffuse optical tomography, photoacoustic imaging, and super-resolution microscopy. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global optical imaging market is segmented - 1) By Product: Imaging Systems, Cameras, Software, Other Products 2) By Application: Pathological Imaging, Intra-operative Imaging 3) By End-User: Hospitals & Clinics, Research Laboratories, Pharmaceutical and Biotechnology Industry

A vascular stent refers to the small metal mesh tubular scaffolds that are used to prevent acute vessel closure and improve blood flow when a vein or artery is too narrow or blocked, resulting in late restenosis in a variety of vessels, such as coronary arteries. The procedure in which these stents are used is known as "vascular stenting." These stents are placed to widen arteries clogged with deposits and to facilitate fast recovery by reducing the risk of infection and physical trauma. The main products of a vascular stent are coronary stents, peripheral vascular stents, and EVAR stent grafts. The coronary stents are used to treat narrowed coronary arteries that provide the heart with oxygen-rich blood and prevent the artery from closing up again. The term "coronary stent" in the vascular stent market refers to a stent that is a small, metal mesh tube that expands inside a coronary artery and is often placed during or immediately after angioplasty. The various types of vascular stents include bare metal stents, bio-engineered stents, bioresorbable vascular scaffolds, drug-eluting stents, and dual therapy stents that are made of metallic, cobalt-chromium, platinum-chromium, nickel titanium, stainless steel, and polymer materials. The modes of delivery include balloon-expandable stents and self-expanding stents that are used in ambulatory surgical center, cardiac center, and hospitals. The vascular stent market research report is one of a series of new reports from The Business Research Company that provides vascular stent market statistics, including vascular stent industry global market size, regional shares, competitors with a vascular stent market share, detailed vascular stent market segments, market trends and opportunities, and any further data you may need to thrive in the vascular stent industry. This vascular stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global vascular stent market size is expected to grow from $13.42 billion in 2022 to $14.67 billion in 2023 at a compound annual growth rate (CAGR) of 9.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The vascular stent market is expected to grow to $20.53 billion in 2027 at a CAGR of 8.8%. Rise in the incidence of vascular diseases will propel the growth of the vascular stent market going forward. Vascular disease refers to an abnormal condition that affects the blood vessels (arteries and veins) and is part of the cardiovascular diseases (CVD) group. The vascular stents help in the treatment of various vascular diseases by enabling the supply of oxygen-rich blood to the heart. For instance, in 2020, according to the Center for Disease Control and Prevention, a US-based federal agency for national public health, approximately 69,700 people died from heart disease, which is 1 in every 5 deaths in the United States. Therefore, an increase in cardiovascular diseases (CVDs) will drive the growth of the vascular stent market. Technological advancement is a key trend gaining popularity in the vascular stent market. Many companies are investing in bio-sensing devices, cutting-edge integrated stents, and drug-eluting coronary stent systems to gain a competitive edge in the market. For instance, in 2022, Translumina, an India-based medical equipment manufacturer launched VIVO ISAR, a latest generation dual drug polymer-free coated stent (DDCS) that brings together a stent with a superior safety profile without compromising the drug release kinetics. It uses Probucol, an antioxidant and lipid-lowering drug, as a carrier for releasing Sirolimus (an anti-restenosis drug), and thus creates a polymer-free DES platform with uncompromised safety and efficacy. In 2021, Royal Philips, a Netherlands-based health technology company, acquired Vesper Medical Inc. for an undisclosed amount. With this acquisition, Philips aims to innovate patient treatment with more sophisticated technology and will expand its portfolio of diagnostic, vascular therapy, and therapeutic devices with an advanced venous stent for the treatment of deep venous disease. Vesper Medical Inc. is a US-based medical technology company that develops minimally invasive peripheral vascular devices. Major players in the vascular stent market are Medtronic Plc., Abbott Laboratories, Boston Scientific Corporation, Biotronik, B. Braun (B. Braun Melsungen), Terumo Corporation, Meril Life Sciences Pvt. Ltd., JOTEC GmbH, W. L. Gore & Associates, Lombard Medical, Microport, Translumina GmbH, Lepu Medical Technology, Philips, Purple Medical Solution Pvt. Ltd., Sahajanand Medical Technologies Pvt. Ltd., Stentys, and Stryker Corporation. North America was the largest region in the vascular stent market in 2022. The regions covered in the vascular stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the vascular stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The vascular stent market consists of sales of bare metal stents, bioresorbable scaffold systems, and drug-eluting balloons. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resale along the supply chain, either further along the supply chain or as part of other products. The global vascular stent market is segmented - 1) By Product: Coronary Stents, Peripheral Vascular Stents, and Evar Stent Grafts 2) By Type: Bare Metal Stent, Bio-Engineered Stent, Bioresorbable Vascular Scaffold, Drug-Eluting Stent, Dual Therapy Stent 3) By Material: Metallic Stents, Cobalt-Chromium, Platinum-Chromium, Nickel-Titanium, Stainless Steel, Polymer Stents 4) By Mode of Delivery: Balloon-expandable Stent, Self-expanding Stent 5) By End-user: Ambulatory Surgical Center, Cardiac Center, Hospital

A spirometer refers to equipment that is used to assess lung health by measuring the amount of air that can be inhaled and exhaled by a person and the duration taken while exhaling the air. These are used to diagnose asthma, chronic obstructive pulmonary disease (COPD), and other conditions that affect breathing. The main types of spirometer include hand-held, tabletop, and desktop. The hand held spirometers are used for longitudinal epidemiological studies to measure and track the forced expiratory volume. The handheld segment of the spirometer market refers to a method of testing the lungs at home without the need for a doctor's visit. The main technologies used in a spirometer include volume measurement, flow measurement, and peak flow measurement. Products include the device, consumables, accessories, and software. The device is used in asthma, COPD, cystic fibrosis, pulmonary fibrosis, and other applications that are used across hospitals, clinics, and home healthcare. The spirometer market research report is one of a series of new reports from The Business Research Company that provides spirometer market statistics, including spirometer industry global market size, regional shares, competitors with a spirometer market share, detailed spirometer market segments, market trends and opportunities, and any further data you may need to thrive in the spirometer industry. This spirometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global spirometer market size is expected to grow from $1.08 billion in 2022 to $1.16 billion in 2023 at a compound annual growth rate (CAGR) of 6.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The spirometer market is expected to grow to $1.49 billion in 2027 at a CAGR of 6.5%. The increase in the prevalence of chronic respiratory diseases is expected to drive the demand for spirometer market going forward. Chronic respiratory diseases are chronic condition of the airways and other parts of the lung such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, cystic fibrosis, sleep apnea, and occupational lung diseases. Portable spirometers have been approved for diagnosing chronic obstructive pulmonary disease (COPD). For instance, in July 2022, according to the Australian Institute of Health and Welfare, the Australian-Government agency reported that one-third (30%) of Australians reported having chronic respiratory conditions. Of the estimated 7.5 million Australians with these conditions, 5.1 million (20% of the total population) had allergic rhinitis ('hay fever'), 2.7 million (11% had asthma), and 2.0 million (8.0%) had chronic sinusitis (ABS 2022). Therefore, the increase in prevalence of chronic respiratory diseases is gaining demand for spirometer market. Technological advancement is a key trend gaining popularity in the spirometer market. Major market players are concentrating their efforts on creating spirometers with innovative technologies like portable wireless spirometers to gain a competitive edge in the market. For instance, on November 2021, Cipla Ltd., an India-based pharmaceutical company, announced the launch of Spirofy, a pneumatic-based portable and wireless spirometer, on World COPD Day. Cipla's Spirofy ensures high result accuracy and individual patient safety using bacterial viral filters (BVF). Spirofy is entirely wireless with good battery backup, making it suitable for use in outdoor camps, remote areas with power shortages, or simply providing physicians with flexibility and ease of use. In February 2020, COSMED, an Italy-based manufacturer of metabolic and body composition technologies, acquired Innovision ApS for an undisclosed amount. The acquisition will help COSMED expand its product portfolio in Pulmonary Function Testing. Innovision ApS is a Danish-based company that designs products for cardiac output, lung clearance index, and metabolic measurements. Major players in the spirometer market are Fukuda Sangyo Co. Ltd., Geratherm Respiratory GmbH, Jones Medical Instrument Company, Koninklijke Philips N.V., Ndd Medical Technologies Inc., nSpire Health Inc., Schiller AG, Sdi Diagnostics Inc., Sibelmed Sau, Smiths Medical Inc., Vitalograph Ltd., Vyaire Medical Inc., Welch Allyn Inc., Baxter International Inc., Benson Medical Instruments Co., Chest M.I. Inc., COSMED srl, Depisteo LLC, Henry Schein Inc., ICU Medical Inc., MGC Diagnostics Corporation, Midmark Corporation, Minato Medical Science Co Ltd., Nuvoair AB, OHD (SCHAUENBURG International, Philips Healthcare, Recorders & Medicare Systems Pvt Ltd., and Teleflex Incorporated. North America was the largest region in the spirometer market in 2022. The regions covered in the spirometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the spirometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The spirometer market consists of sales of whole-body plethysmographs, pneumotachometers, fully electronic spirometers, peak flow meters, incentive spirometers, and windmill-type spirometers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resale along the supply chain, either further along the supply chain or as part of other products. The global spirometer market is segmented - 1) By Type: Handheld, Table Top, Desktop 2) By Technology: Volume Measurement, Flow Measurement, and Peak Flow Measurement 3) By Product: Devices, Consumables, and Accessories, Software 4) By Application: Asthma, COPD, Cystic Fibrosis, Pulmonary Fibrosis, Other Applications 5) By End-Use: Hospitals and Clinics, Home Healthcare

Wound closure devices refer to internal consistency, reliability, and mechanical gear that help in wound closure by bringing wound tissue margins closer together. The wound closure devices are used to stop the bleeding, prevent infection, accelerate healing, and preserve the look and function of the damaged region. The main types of wound closure devices are adhesives, staples, sutures, strips, sealants, and mechanical wound closure devices. Adhesive refers to any substance that is capable of holding materials together in a functional manner by a surface attachment that resists separation. The wound types are chronic and acute. The various end-users involved hospitals, clinics, trauma centers, and other end-users. The wound closure devices market research report is one of a series of new reports from The Business Research Company that provides wound closure devices market statistics, including wound closure devices industry global market size, regional shares, competitors with a wound closure devices market share, detailed wound closure devices market segments, market trends and opportunities, and any further data you may need to thrive in the wound closure devices industry. This wound closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global wound closure devices market size is expected to grow from $14.64 billion in 2022 to $15.90 billion in 2023, at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The wound closure devices market size is expected to grow to $21.46 billion in 2027 at a CAGR of 7.8%. The increase in number of patients undergoing surgeries is expected to propel the growth of the wound closure devices market going forward. Surgery refers to a medical specialty that employs operative manual and instrumental procedures on a person to evaluate or treat a pathological condition, such as a sickness or injury, to enhance body function and attractiveness, or to mend undesirable ruptured regions. Wound closure devices are used to treat chronic, traumatic, and surgical wounds, skin grafts, and flaps. For instance, in April 2022, according to the American Society for Aesthetic Plastic Surgery, a US-based organization of plastic surgeons, there has been a considerable growth in operations on the face, breast, and body. Since 2020, attractive body operations such as abdominoplasty, buttock augmentation, and liposuction have climbed by 63%. Breast augmentation, augmentation with a breast lift, and breast lift with reduction treatments increased by 48%. Last year, specialized facial surgeries such as brow lifts and facelifts increased by 54%. Therefore, the increasing number of patients undergoing surgeries is driving the growth of the wound closure devices market. Technological advancements are a key trend gaining popularity in the wound closure devices market. Major companies operating in the wound closure devices market are focused on developing new technological solutions flexible across other elements to gain a competitive edge in the market. For instance, in March 2021, Ethicon Endo-Surgery, a US-based advanced medical device company, launched an ECHELONTM+ Stapler with GST Reloads, a new powered surgical stapler that has been designed for increasing staple line security and will reduce complications through uniform tissue compression and better staple formation, even in challenging situations. This has Gripping Surface Technology (GST) reloads for more consistent compression to better capture and form staples, and a motor with Dynamic Firing, which optimizes firing speed in thick tissue to improve compression. In December 2021, Essity AB, a Sweden-based hygiene and health company, acquired Hydrofera LLC for an amount of $116 million. This acquisition is expected to support Essity's strategic goal of expanding its medical solutions business through acquisitions. This agreement will increase Essity's capability for innovation and broaden its selection of sophisticated wound care products. Hydrofera LLC is a US-based company operating in wound closure devices. Major players in the wound closure devices market are Abbott Laboratories, Arthrex Inc., B Braun Melsungen AG, Baxter International Inc., Boston Scientific Corporation, BSN Medical GmbH, Coloplast A/S, ConvaTec Group PLC, CryoLife Inc., DACH Medical Group, DeRoyal Industries Inc., Dolphin Sutures, Integra LifeSciences Corporation, IVT Medical Limited, Johnson & Johnson Services Inc., Chemence Medical Inc., Healthium Medtech Private Limited, Meril Life Sciences Private Limited, Futura Surgicare Private Limited, and Advanced Medical Solutions Group plc. North America was the largest region in the wound closure devices market in 2022. The regions covered in the wound closure devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the wound closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and the USA. The wound closure devices market consists of sales of hemostatic agents and ligating clips. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global wound closure devices market is segmented - 1) By Product Type: Adhesives, Staples, Sutures, Strips, Sealants, Mechanical Wound Closure Devices 2) By Wound Type: Chronic, Acute 3) By End-Use: Hospital, Clinics, Trauma centers, Other End-Users